Skip to main content

Theseus Pharmaceuticals, Inc.

THRXDelisted Feb 14, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001745020

Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Theseus Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
+5 vs. Q1 2022
Shares held
34.7M
−291.9K (−0.8%) vs. Q1 2022
Total value
$191.6M
−$211.1M (−52.4%) vs. Q1 2022
New holders
7
23 more added
Sold out
2
11 more reduced

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 51 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 47 institutionsQ2 2022: 51 institutionsQ3 2022: 51 institutionsQ4 2022: 47 institutionsQ1 2023: 72 institutionsQ2 2023: 69 institutionsQ3 2023: 63 institutionsQ4 2023: 70 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $191.6M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $441.4MQ1 2022: $402.8MQ2 2022: $191.6MQ3 2022: $200.7MQ4 2022: $164.8MQ1 2023: $350.6MQ2 2023: $373.6MQ3 2023: $95.5MQ4 2023: $145.8MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding THRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$0
Q4 202370$145.8M
Q3 202363$95.5M
Q2 202369$373.6M
Q1 202372$350.6M
Q4 202247$164.8M
Q3 202251$200.7M
Q2 202251$191.6M
Q1 202247$402.8M
Q4 202146$441.4M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding THRX in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC17,041,668$94.2M1.83%00.0%Unchanged
FMR LLC5,183,363$28.7M0.00%−374,084−6.7%Reduced
Foresite Capital Management V, LLC3,335,346$18.4M12.89%+122,614+3.8%Added
Price T Rowe Associates Inc1,385,283$7.66M0.00%−51,333−3.6%Reduced
Foresite Capital Opportunity Management V, LLC959,275$5.30M13.37%+490,455+104.6%Added
Boxer Capital, LLC892,057$4.93M0.31%00.0%Unchanged
Omega Fund Management, LLC711,479$3.93M1.26%00.0%Unchanged
BlackRock Inc.687,359$3.80M0.00%+142,504+26.2%Added
Vanguard Group Inc629,314$3.48M0.00%+142,952+29.4%Added
Nextech Invest AG611,310$3.38M1.14%00.0%Unchanged
Lynx1 Capital Management LP504,862$2.79M2.38%+148,035+41.5%Added
Rock Springs Capital Management LP437,329$2.42M0.07%00.0%Unchanged
Farallon Capital Management, L.L.C.409,717$2.27M0.01%−114,262−21.8%Reduced
Geode Capital Management, LLC256,139$1.42M0.00%+53,703+26.5%Added
State Street Corp233,893$1.29M0.00%+51,232+28.0%Added
Woodline Partners LP211,684$1.17M0.02%−38,316−15.3%Reduced
Laurion Capital Management LP179,619$994.0K0.04%00.0%Unchanged
Ensign Peak Advisors, Inc142,598$788.0K0.00%−107,402−43.0%Reduced
Northern Trust Corp128,060$708.0K0.00%+30,921+31.8%Added
TD Asset Management Inc106,948$591.0K0.00%+39,815+59.3%Added
Tekla Capital Management LLC100,000$553.0K0.02%00.0%Unchanged
DAFNA Capital Management LLC81,899$453.0K0.12%+1,775+2.2%Added
Wellington Management Group LLP60,155$332.0K0.00%−233,432−79.5%Reduced
Manufacturers Life Insurance Company, The55,883$290.8K0.00%−4,040−6.7%Reduced
Charles Schwab Investment Management Inc43,327$240.0K0.00%+11,098+34.4%Added
Bank of New York Mellon Corp38,811$214.0K0.00%+9,432+32.1%Added
Opaleye Management Inc.32,300$179.0K0.08%+32,300New
Nuveen Asset Management, LLC31,718$175.0K0.00%+14,224+81.3%Added
Walleye Capital LLC31,719$175.0K0.01%+31,719New
Rhumbline Advisers23,405$129.0K0.00%+23,405New
Susquehanna International Group, LLP22,402$124.0K0.00%+22,402New
Morgan Stanley12,633$70.0K0.00%+2,985+30.9%Added
Deutsche Bank AG10,549$58.0K0.00%+4,296+68.7%Added
D. E. Shaw & Co., Inc.10,412$58.0K0.00%+10,412New
New York State Common Retirement Fund9,495$53.0K0.00%00.0%Unchanged
JPMorgan Chase & Co9,084$50.0K0.00%+3,687+68.3%Added
American International Group, Inc.7,952$44.0K0.00%+2,238+39.2%Added
California State Teachers Retirement System7,266$40.0K0.00%+2,340+47.5%Added
Bank of America Corp6,394$35.0K0.00%+1,320+26.0%Added
Barclays PLC5,192$29.0K0.00%−1,018−16.4%Reduced
Tower Research Capital LLC (TRC)2,663$15.0K0.00%+1,255+89.1%Added
STRS Ohio2,700$14.0K0.00%00.0%Unchanged
Amalgamated Bank1,901$11.0K0.00%+231+13.8%Added
Legal & General Group Plc1,962$11.0K0.00%+903+85.3%Added
Citigroup Inc1,173$6.00K0.00%+724+161.2%Added
High Net Worth Advisory Group LLC800$4.00K0.00%−500−38.5%Reduced
Ameritas Investment Partners, Inc.889$4.00K0.00%00.0%Unchanged
Wells Fargo & Company173$1.00K0.00%−2,326−93.1%Reduced
Royal Bank of Canada96$1.00K0.00%−611−86.4%Reduced
Credit Suisse AG14$00.00%+14New
Castle Wealth Management LLC50$00.00%+50New
Adage Capital Partners GP, L.L.C.0$00.00%−761,589−100.0%Sold out
UBS Group AG0$00.00%−2,041−100.0%Sold out
Amalgamated Financial Corp.––––Not filed